These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 26703191)
21. Characteristics and potential clinical applications of the extracellular vesicles of human pathogenic Fungi. Ullah A; Huang Y; Zhao K; Hua Y; Ullah S; Rahman MU; Wang J; Wang Q; Hu X; Zheng L BMC Microbiol; 2023 Aug; 23(1):227. PubMed ID: 37598156 [TBL] [Abstract][Full Text] [Related]
22. Fungal lipids: biosynthesis and signalling during plant-pathogen interaction. Beccaccioli M; Reverberi M; Scala V Front Biosci (Landmark Ed); 2019 Jan; 24(1):172-185. PubMed ID: 30468650 [TBL] [Abstract][Full Text] [Related]
23. Glucose Transporter and Sensor Mechanisms in Fungal Pathogens as Potential Drug Targets. Navale AM Curr Rev Clin Exp Pharmacol; 2024; 19(3):250-258. PubMed ID: 37861001 [TBL] [Abstract][Full Text] [Related]
24. Lightning up the worm: How to probe fungal virulence in an alternative mini-host by bioluminescence. Krappmann S Virulence; 2015; 6(8):727-9. PubMed ID: 26537579 [No Abstract] [Full Text] [Related]
25. Fungal virulence genes as targets for antifungal chemotherapy. Perfect JR Antimicrob Agents Chemother; 1996 Jul; 40(7):1577-83. PubMed ID: 8807043 [TBL] [Abstract][Full Text] [Related]
26. Extracellular Vesicles in the Fungi Kingdom. Liebana-Jordan M; Brotons B; Falcon-Perez JM; Gonzalez E Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281276 [TBL] [Abstract][Full Text] [Related]
27. [Resistance to antimycotics: role of calcineurin and protein kinases]. Nikitin AV Antibiot Khimioter; 2009; 54(3-4):3-5. PubMed ID: 19711840 [No Abstract] [Full Text] [Related]
28. Galleria mellonella: An invertebrate model to study pathogenicity in correctly defined fungal species. Binder U; Maurer E; Lass-Flörl C Fungal Biol; 2016 Feb; 120(2):288-95. PubMed ID: 26781383 [TBL] [Abstract][Full Text] [Related]
29. The importance of fungal pathogens and antifungal coatings in medical device infections. Giles C; Lamont-Friedrich SJ; Michl TD; Griesser HJ; Coad BR Biotechnol Adv; 2018; 36(1):264-280. PubMed ID: 29199134 [TBL] [Abstract][Full Text] [Related]
37. A mini-review of recent W.O. patents (2004-2005) of novel anti-fungal compounds in the field of anti-infective drug targets. Zhang W; Becker D; Cheng Q Recent Pat Antiinfect Drug Discov; 2006 Jun; 1(2):225-30. PubMed ID: 18221147 [TBL] [Abstract][Full Text] [Related]
38. The role of melanins in melanotic fungi for pathogenesis and environmental survival. Eisenman HC; Greer EM; McGrail CW Appl Microbiol Biotechnol; 2020 May; 104(10):4247-4257. PubMed ID: 32206837 [TBL] [Abstract][Full Text] [Related]
39. Antifungal drug resistance of pathogenic fungi. Kontoyiannis DP; Lewis RE Lancet; 2002 Mar; 359(9312):1135-44. PubMed ID: 11943280 [TBL] [Abstract][Full Text] [Related]
40. Aspartic proteinases of Candida spp.: role in pathogenicity and antifungal resistance. Silva NC; Nery JM; Dias AL Mycoses; 2014 Jan; 57(1):1-11. PubMed ID: 23735296 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]